Pratt R M, Willis W D
Proc Natl Acad Sci U S A. 1985 Sep;82(17):5791-4. doi: 10.1073/pnas.82.17.5791.
We have tested 35 teratogenic and 20 nonteratogenic chemicals or drugs in a short-term, in vitro assay that identifies teratogens by their ability to inhibit growth of an established line of human embryonic palatal mesenchymal cells. Only those chemicals that exhibited a dose-dependent inhibition of growth at concentrations less than 1 mM were classified as inhibitory. An Aroclor-induced rat liver S-9 system was effective in metabolizing cyclophosphamide to its teratogenic form in culture. We suggest that this assay, along with the complementary tumor cell-attachment assay of Braun et al. [Braun, A. G., Emerson, D. J. & Nichinson, B. B. (1979) Nature (London) 282, 507-509] may be useful as a short-term in vitro battery for assessment of the teratogenic potential in environmental agents and to prioritize those chemicals which merit further testing in vivo.
我们已经在一项短期体外试验中测试了35种致畸化学物质和药物以及20种非致畸化学物质或药物,该试验通过已建立的人类胚胎腭间充质细胞系的生长抑制能力来识别致畸物。只有那些在浓度低于1 mM时表现出剂量依赖性生长抑制的化学物质才被归类为具有抑制作用。阿罗氯丹诱导的大鼠肝脏S-9系统在培养中将环磷酰胺代谢为其致畸形式的过程中是有效的。我们认为,该试验与布劳恩等人[布劳恩,A.G.,爱默生,D.J.和尼科尔森,B.B.(1979年)《自然》(伦敦)282,507 - 509]的互补肿瘤细胞附着试验一起,可能作为一种短期体外试验组合,用于评估环境因子的致畸潜力,并对那些值得进一步进行体内试验的化学物质进行优先排序。